Clinical Trial

Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects.

Recruiting
View on ClinicalTrials.gov →
Summary
PTC(Pseudotumor cerebri) patients may develop increased Intracranial pressure (ICP) that can produces increased pressure around the distal optic nerve,which is likely followed by venule compression, ischemia, and loss of visual function.Vision loss in PTC is most commonly characterized by standard automated perimetry to measure peripheral visual field sensitivity. Pupillometry is a promising approach for functional assessment in PTC because it is noninvasive, objective, performed quickly with minimal patient cooperation needed. The feasibility of using chromatic multifocal pupillometry for assesment of PTC will be examined.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2017-10-03; most recent amendment 2025-09-30.
Status change: Not Yet Recruiting → Recruiting 2019-02-17
Trial Details
NCT Number NCT03304314
Lead Sponsor Sheba Medical Center
Conditions Pseudotumor Cerebri
Enrollment 100 participants
Start Date 2017-11-03
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-06